| study indicates that miR-203 exerts a tumor-suppressive effect during laryngeal carcinogenesis via suppressing the expression of survivin | laryngeal, |
| a novel role for miR-203 as a tumor suppressor acting by inducing senescence in melanoma cells. | skin, |
| microRNAs that jointly act as tumor suppressors in prostate carcinoma | prostate, |
| Data suggest that miR-203 may function as a tumor suppressor in triple negative breast cancer cells. | breast, |
| MiR-203 may act as novel tumor suppressor in esophageal cancer through down-regulating the expression of Ran and miR-21. | esophageal, |
| miR-203 plays a role as a tumour suppressor in laryngeal squamous cell carcinoma (LSCC). | laryngeal, |
| In chemically induced skin neoplasms, tumor suppressor miR-203 is downregulated at 16 weeks. | skin,neoplasm, |
| our results demonstrated that miR-203 act as a tumor suppressor miRNA through regulating RAB22A expression and suggested its involvement in osteosarcoma progression and carcinogenesis. | osteosarcoma, |
| Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development | esophageal, |
| miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer | ovarian, |
| The findings suggest that miR-203 is a tumor suppressor that plays an important role in inhibiting the occurrence of Kazakh esophageal squamous cell carcinoma in China via regulating the expression of p63. | esophageal, |
| miR203 acts as a tumor suppressor in glioblastoma by suppressing the pro-tumorigenic action of STAT1. | glioblastoma, |
| Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma | gastric, |
| MiR-203a targets IGF-1R and functions as a tumor suppressor in gastric cancer. | gastric, |
| MiR-203a functions as a tumor suppressor in bladder cancer by targeting SIX4 | bladder, |
| MicroRNA?203a?3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma | colorectal, |
| Expression of miR-203 reduces ABL1 and BCR-ABL1 fusion protein levels and inhibits tumor cell proliferation in an ABL1-dependent manner, suggesting it may function as a tumor suppressor. | None |
| The miR-203 functions as a tumor suppressor by targeting VEGFA, resulting in the inhibition of tumor growth and angiogenesis. | None |
| miR-203 functions as a tumor suppressor in RMS development. | None |
| The miR-203 played tumor suppressive roles by downregulating ADAM9 and HULC and indicated its potential application in cancer treatment. | None |